THE Australian Medical Association (AMA) has welcomed updated Ahpra guidelines to curb unsafe prescribing of medicinal cannabis amid rising prescriptions and reports of harm, including psychosis. AMA President Dr Danielle McMullen warned that direct-to-consumer telehealth models bypass traditional safeguards, posing risks. The new guidance stresses thorough patient assessment, clear therapeutic justification, coordination with GPs, and real-time prescription monitoring.
DOCTOR'S WARNING OVER MEDICAL CANNABIS

editor
Publisher
Michael Walls
michael@accessnews.com.au
0407 783 413